Literature DB >> 15250012

[Size and shape of commercially available polyethylene particles for in-vitro and in-vivo-experiments].

M von Knoch1, C Sprecher, B Barden, G Saxler, F Löer, M Wimmer.   

Abstract

AIM: The longevity of total hip arthroplasty is sometimes limited by osteolysis and aseptic loosening. Aseptic loosening may be caused by the biologic reaction to polyethylene wear particles. Particles of less than 1 micro m diameter are of particular importance. These particles are not easily available for experimental use.
METHOD: We performed a morphologic analysis of commercially available, very small polyethylene particles (Ceridust(R)) in order to determine the specific size distribution. We measured 1 978 particles. Size analysis was performed using an electron microscope. Particle size was described as the equivalent circle diameter (ECD). Particle morphology was described as feret ratio. In addition, Ceridust(R) particles were compared to different particles stemming from a hip simulator experiment.
RESULTS: More than 35 % of the particles were less than 1 micro m in size. The particle size was 1.75 micro m +/- 1.43 micro m (median 1.42 micro m). The minimum was 0.06 micro m, the maximum was 11.06 micro m. The feret ratio was 0.58 +/- 0.17 (median 0.63). The minimum was 0.07, the maximum was 0.93. The majority of Ceridust(R) particles had a rough surface. Compared to polyethylene particles stemming from a hip simulator experiment, Ceridust(R) particles had a rougher surface, were less longitudinal, and had a more even size distribution.
CONCLUSIONS: The pure, commercially available polyethylene particles analyzed here are suitable for in vitro and in vivo experiments due to their easy availability, minor costs, and large fraction of very small particles.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15250012     DOI: 10.1055/s-2004-822589

Source DB:  PubMed          Journal:  Z Orthop Ihre Grenzgeb        ISSN: 0044-3220


  7 in total

1.  Alpha-calcitonin gene-related peptide can reverse the catabolic influence of UHMWPE particles on RANKL expression in primary human osteoblasts.

Authors:  Max D Kauther; Jie Xu; Christian Wedemeyer
Journal:  Int J Biol Sci       Date:  2010-09-15       Impact factor: 6.580

2.  Effects of alpha-calcitonin gene-related peptide on osteoprotegerin and receptor activator of nuclear factor-κB ligand expression in MG-63 osteoblast-like cells exposed to polyethylene particles.

Authors:  Jie Xu; Max D Kauther; Julia Hartl; Christian Wedemeyer
Journal:  J Orthop Surg Res       Date:  2010-11-04       Impact factor: 2.359

3.  Early changes in serum osteocalcin and body weight are predictive of implant fixation in a rat model of implant loosening.

Authors:  Brittany M Wilson; Meghan M Moran; Matthew J Meagher; Ryan D Ross; Maleeha Mashiatulla; Amarjit S Virdi; Dale R Sumner
Journal:  J Orthop Res       Date:  2019-12-25       Impact factor: 3.494

4.  Polyethylene wear particles induce TLR 2 upregulation in the synovial layer of mice.

Authors:  A C Paulus; J Frenzel; A Ficklscherer; B P Roßbach; C Melcher; V Jansson; S Utzschneider
Journal:  J Mater Sci Mater Med       Date:  2013-11-19       Impact factor: 3.896

5.  Peri-implant and systemic effects of high-/low-affinity bisphosphonate-hydroxyapatite composite coatings in a rabbit model with peri-implant high bone turnover.

Authors:  Shun Niu; Xiaorui Cao; Yan Zhang; Qingsheng Zhu; Jinyu Zhu; Ping Zhen
Journal:  BMC Musculoskelet Disord       Date:  2012-06-11       Impact factor: 2.362

6.  Calcitonin substitution in calcitonin deficiency reduces particle-induced osteolysis.

Authors:  Max D Kauther; Hagen S Bachmann; Laura Neuerburg; Martina Broecker-Preuss; Gero Hilken; Florian Grabellus; Gabriele Koehler; Marius von Knoch; Christian Wedemeyer
Journal:  BMC Musculoskelet Disord       Date:  2011-08-15       Impact factor: 2.362

7.  The influence of calcitonin gene-related peptide on markers of bone metabolism in MG-63 osteoblast-like cells co-cultured with THP-1 macrophage-like cells under virtually osteolytic conditions.

Authors:  Heidrun Jablonski; Heike Rekasi; Marcus Jäger
Journal:  BMC Musculoskelet Disord       Date:  2016-05-04       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.